Surgery: Risks of hemodynamic instability in pheochromocytoma

Nature Reviews Endocrinology

Volumn 6, Issue 6, 2010, Pages 301-302

  Eisenhofer, Graeme ^a   Bornstein, Stefan R ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DOXAZOSIN; PHENOXYBENZAMINE;

ADRENAL INSUFFICIENCY; DIASTOLIC BLOOD PRESSURE; HEMODYNAMIC PARAMETERS; HYPERTENSION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SYSTOLIC BLOOD PRESSURE;

ADRENAL GLAND NEOPLASMS; ADRENERGIC ALPHA-ANTAGONISTS; CARDIOVASCULAR DISEASES; CATECHOLAMINES; ENDOCRINE SURGICAL PROCEDURES; HEMODYNAMICS; HUMANS; PHENOXYBENZAMINE; PHEOCHROMOCYTOMA; PREOPERATIVE CARE; RISK FACTORS;

EID: 77952913702     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2010.65     Document Type: Short Survey

References (10)

1. Bruynzeel, H. et al. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J. Clin. Endocrinol. Metab. 95, 678-685 (2010).
2. Kinney, M. A. et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth. Analg. 91, 1118-1123 (2000).
3. Plouin, P. F., Duclos, J. M., soppelsa, F., Boublil, G. & Chatellier, G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J. Clin. Endocrinol. Metab. 86, 1480-1486 (2001).
4. Pacak, K. Preoperative management of the pheochromocytoma patient. J. Clin. Endocrinol. Metab. 92, 4069-4079 (2007).
5. Mannelli, M. Management and treatment of pheochromocytomas and paragangliomas. Ann. NY Acad. Sci. 1073, 405-416 (2006).
6. Pacak, K. et al. Pheochromocytoma: recommendations for clinical practice from the First international symposium. October 2005. Nat. Clin. Pract. Endocrinol. Metab. 3, 92-102 (2007).
7. Prys-Roberts, C. & Farndon, J. R. efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J. Surg. 26, 1037-1042 (2002).
8. Eisenhofer, G. et al. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma. Am. J. Physiol. Endocrinol. Metab. 295, e1223-e1233 (2008).
9. Eisenhofer, G. et al. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf. 30, 1031-1062 (2007).
10. Bornstein, S. R. Predisposing factors for adrenal insufficiency. N. Engl. J. Med. 360, 2328-2339 (2009).